A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression
Phase: PHASE2 | Sponsor: University of Washington | Compound: Psilocybin
- Status
- recruiting
- Institution
- University of Washington
- Start date
- 2026-04-01
- End date
- 2027-12-31
- Registry ID
- NCT07336238
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.